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A B S T R A C T
Background
Trauma-induced coagulopathy (TIC) is a disorder of the blood clotting process that occurs soon after trauma injury. A diagnosis of TIC
on admission is associated with increased mortality rates, increased burdens of transfusion, greater risks of complications and longer
stays in critical care. Current diagnostic testing follows local hospital processes and normally involves conventional coagulation tests
including prothrombin time ratio/international normalized ratio (PTr/INR), activated partial prothrombin time and full blood count.
In some centres, thromboelastography (TEG) and rotational thromboelastometry (ROTEM) are standard tests, but in the UK they are
more commonly used in research settings.
Objectives
The objective was to determine the diagnostic accuracy of thromboelastography (TEG) and rotational thromboelastometry (ROTEM)
for TIC in adult trauma patients with bleeding, using a reference standard of prothrombin time ratio and/or the international normalized
ratio.
Search methods
We ran the search on 4 March 2013. Searches ran from 1970 to current. We searched The Cochrane Library, MEDLINE (OvidSP),
EMBASE Classic and EMBASE, eleven other databases, the web, and clinical trials registers. The Cochrane Injuries Group’s specialised
register was not searched for this review as it does not contain diagnostic test accuracy studies. We also screened reference lists, conducted
forward citation searches and contacted authors.
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Selection criteria
We included all cross-sectional studies investigating the diagnostic test accuracy of TEG and ROTEM in patients with clinically
suspected TIC, as well as case-control studies. Participants were adult trauma patients in both military and civilian settings. TIC was
defined as a PTr/INR reading of 1.2 or greater, or 1.5 or greater.
Data collection and analysis
We piloted and performed all review stages in duplicate, including quality assessment using the QUADAS-2 tool, adhering to guidance
in the Cochrane Handbook for Diagnostic Test Accuracy Reviews. We analysed sensitivity and specificity of included studies narratively
as there were insufficient studies to perform a meta-analysis.
Main results
Three studies were included in the final analysis. All three studies used ROTEM as the test of global haemostatic function, and none of
the studies used TEG. Tissue factor-activated assay EXTEM clot amplitude (CA) was the focus of the accuracy measurements in blood
samples taken near to the point of admission. These CAs were not taken at a uniform time after the start of the coagulopathic trace; the
time varied from five minutes, to ten minutes and fifteen minutes. The three included studies were conducted in the UK, France and
Afghanistan in both civilian and military trauma settings. In two studies, median Injury Severity Scores were 12, inter-quartile range
(IQR) 4 to 24; and 22, IQR 12 to 34; and in one study the median New Injury Severity Score was 34, IQR 17 to 43.
There were insufficient included studies examining each of the three ROTEM CAs at 5, 10 and 15 minutes to make meta-analysis and
investigation of heterogeneity valid. The results of the included studies are thus reported narratively and illustrated by a forest plot and
results plotted on the receiver operating characteristic (ROC) plane.
For CA5 the accuracy results were sensitivity 70% (95% CI 47% to 87%) and specificity 86% (95% CI 82% to 90%) for one study,
and sensitivity 96% (95% CI 88% to 100%) and specificity 58% (95% CI 44% to 72%) for the other.
For CA10 the accuracy results were sensitivity 100% (95% CI 94% to 100%) and specificity 70% (95% CI 56% to 82%).
For CA15 the accuracy results were sensitivity 88% (95% CI 69% to 97%) and specificity 100% (95% CI 94% to 100%).
No uninterpretable ROTEM study results were mentioned in any of the included studies.
Risk of bias and concerns around applicability of findings was low across all studies for the patient and flow and timing domains.
However, risk of bias and concerns around applicability of findings for the index test domain was either high or unclear, and the risk of
bias for the reference standard domain was high. This raised concerns around the interpretation of the sensitivity and specificity results
of the included studies, which may be misleading.
Authors’ conclusions
We found no evidence on the accuracy of TEG and very little evidence on the accuracy of ROTEM. The value of accuracy estimates
are considerably undermined by the small number of included studies, and concerns about risk of bias relating to the index test and
the reference standard. We are unable to offer advice on the use of global measures of haemostatic function for trauma based on the
evidence on test accuracy identified in this systematic review. This evidence strongly suggests that at present these tests should only be
used for research. We consider more thoroughly what this research could be in the Discussion section.
P L A I N L A N G U A G E S U M M A R Y
TEG and ROTEM for diagnosing trauma induced coagulopathy (disorder of the clotting system) in adult trauma patients
with bleeding
What is ’trauma-induced coagulopathy’?
Trauma-induced coagulopathy (TIC) is a disorder of the blood clotting process that can occur soon after trauma injury that can lead to
the patient bleeding to death. A diagnosis of TIC on admission to hospital is associated with increases in death rates, blood transfusions,
risks of complications and length of stay in hospital.
How is TIC diagnosed?
Current testing for TIC normally involves coagulation tests on the patient’s blood.
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What are thromboelastography (TEG) and rotational thromboelastometry (ROTEM)?
Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) are tests which involve a group of assessments that can be
used to diagnose TIC. In some centres TEG and ROTEM are used routinely to test patients’ blood, but in the UK their use is usually
restricted to experimental and research settings.
The purpose of this research
The purpose of this research was to determine how good the TEG and ROTEM assessments are at diagnosing TIC in adult trauma
patients who are bleeding. The accuracy of TEG and ROTEM was compared against another test that is currently used (the reference
standard), which was the prothrombin time/international normalized ratio (PTr/INR).
What we discovered
We identified 3 studies (with 300, 90 and 40 participants; 430 in total) that compared the diagnostic test accuracy of TEG or ROTEM
for identifying TIC in bleeding adult trauma patients within the emergency setting against PTr/INR. Readers should note that the
assessment of test accuracy was not the single purpose of any of these 3 included studies.
None of the 3 studies investigated the accuracy of the TEG assessment; they all investigated the ROTEM assessment. The 3 studies
provided very little evidence on the accuracy of ROTEM, and provided results for only one potential indicator of TIC (clot amplitude
(CA) at 5, 10 and 15 minutes (CA5, CA10 and CA15)), although other indicators could have been used.
The overall reliability of the estimates of accuracy for CA was undermined by the low number of studies (2 for CA5 measurements
and 1 each for CA10 and CA15 measurements), as well as concerns that the studies might be subject to bias concerning aspects of the
ROTEM test and the PTr/INR test being used as the reference standard.
There was not enough research available on the test accuracy of TEG or ROTEM for the researchers to determine whether these
assessments provide a good test for diagnosing TIC in bleeding adult trauma patients.
This evidence strongly suggests that at the moment these tests should only be used for research. The review emphasises that it is not
enough to define the index test solely in terms of the device (TEG and ROTEM). Both ROTEM and TEG offer a number of measures:
time to initiate clotting; time of clot formation; alpha angle; clot amplitude; maximum strength of clot; time to maximum clot strength;
time to lysis of different degrees. These are illustrated in Figure 7. In addition, the protocol for initiating clotting also needs to be
specified e.g. INTEM, EXTEM or FIBTEM in the case of ROTEM. Greater clarity is needed on which of these measures is most
reliable and which is most relevant for particular clinical tasks; there may be more than one. Finally, different test evaluations may help
in assessing these various aspects of the tests. Evaluations of predictive studies may shed light on the link between test result and patient
outcome, and provide insight into the best treatment strategies for this condition and patient group. The authors of this review are
currently conducting a review of such predictive studies, and this is registered on the International Prospective Register of Systematic
Reviews (PROSPERO).
B A C K G R O U N D
Target condition being diagnosed
Trauma-induced coagulopathy (TIC) can be defined as an impair-
ment of blood clotting that occurs soon after injury (Frith 2010).
A diagnosis of TIC on admission to hospital carries a mortality
rate amongst patients of up to 50%, and is often associated with
increased burdens of transfusion, greater risks of organ injury and
septic complications, and longer stays in critical care (Brohi 2003;
MacLeod 2003; Maegele 2007). Worldwide, trauma is the lead-
ing cause of mortality and disability in adults under the age of 36
years (Hess 2009), and in the UK 40% of all trauma deaths are
as a result of haemorrhage (Frith 2010), whilst shock and coagu-
lopathy upon admission have both been independently associated
with both massive transfusion and increased mortality (Spinella
2009). Equally in the combat setting, bleeding is the largest cause
of death on the battlefield (Holcomb 2007).
Various terms such as TIC, ‘acute traumatic coagulopathy’ (ATC)
and ‘acute coagulopathy of trauma shock’ are used to describe
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these early coagulation changes. None of these terms have taken
particular precedence and all are widespread within the trauma
literature. For the purposes of this review we will use the term TIC
to describe the hypocoagulable changes that occur within the first
24 hours following injury due to a variety of different and highly
interlinked causes, i.e. hypoperfusion, ongoing bleeding and con-
sumption of clotting factors, haemodilution, acidosis, hypother-
mia and ATC.
In the absence of embedded clinical consensus, the coagulopathic
range we use is based on prothrombin time ratio (PTr)/interna-
tional normalized ratio (INR). Two different coagulopathic ranges
are commonly used within the research and clinical literature: a
PTr/INR count of 1.2 or above; and a PTr/INR count of 1.5 or
above is considered coagulopathic (further detail is given in the
section on Reference standards). We will be including both these
ranges within our review. This decision was reached through re-
view of the literature and discussion with the report authors, in-
cluding experts in haematology and trauma medicine.
The aetiology of coagulopathy associated with trauma is not fully
understood. In non-trauma situations, blood clots form through
a chain of actions; first, platelets form a sticky clump on the blood
vessel wall at the site of injury. This clot is weak, but soon a cas-
cade of clotting proteins generates fibrin, a protein that meshes
the platelets and some red blood cells together to produce a far
stronger clot. This process is called coagulation, but it can become
disordered; this happens in around a quarter of trauma patients.
The underlying reasons for this disruption are still unknown, but
the combination of tissue damage and shock are contributory fac-
tors, as is the presence of hypoperfusion through severe blood loss
(Barts & The London 2011).
Early recognition of the nature of the clotting defect has been
acknowledged as increasingly important to guide replacement of
clotting factors alongside blood volume maintenance and red cell
replacement. There are, however, no validated methods to guide
therapy effectively. This leads to both over-transfusion and under-
transfusion, reduction in efficacy, increased wastage and exposure
to risk. These issues can be exacerbated in disasters where timely
availability of blood and component therapy is vital but severely
resource constrained.
Clinical pathway
Standard blood tests are performed as soon as possible on every
patient with bleeding who arrives at the hospital emergency de-
partment (see diagnostic pathway in Figure 1). There is no hier-
archy of tests performed at admission, but rather a group of tests
are used - i.e. activated partial thromboplastin time (APTT), PTr/
INR and full blood count (FBC). The choice of these tests is highly
variable and follows local hospital practice. In some centres, espe-
cially across Europe, thromboelastography (TEG) and rotational
thromboelastometry (ROTEM) are standard tests. In the UK, the
use of TEG and ROTEM is increasing, but has - up until now -
been mainly used in research settings.
Figure 1. Clinical pathway for emergency department identification of trauma-induced coagulopathy
Current tests
Traditional measures of clotting (such as platelet count, bleeding
time, prothrombin time (PT and APTT) have some limitations
in the context of managing trauma. Amongst these,
• platelet count provides data about how many platelets are
present, but gives no information about how they function;
• bleeding time measured through the application of a cuff
also assesses platelet function, but is impractical in the bleeding
patient and is thus rarely used;
• fibrinogen tests measure the functional ability of the
available fibrinogen, but this test therefore measures only one
part of the coagulation system and does not give an overall
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indication of haemostatic potential; and
• PT and APTT only provide a measure of time before initial
thrombin generation, they are performed on platelet-poor
plasma, were designed to evaluate clotting factor deficiencies (not
acquired coagulopathy), and are known to be poor predictors of
bleeding in these circumstances (Dzik 2004).
In addition, evidence has suggested that APTTandPT are not able
to provide an indication of when a patient is in a hypercoagulable
state (Park 2009).
Despite these weaknesses, in practical terms PT remains the cur-
rent standard of practice, although it measures a late change in
haemostasis and is not a sensitive measure (Brohi 2013).
Index tests
Newer global haemostatic function technologies such as TEG and
ROTEM enable ‘point of care’ measurement, using whole blood
samples, of the initiation and progress of coagulation as well as
final clot strength and lysis and the dynamics of clot formation.
For the purposes of this study, TEG and ROTEM are envisaged
as a replacement test for traditional coagulation tests. Both tests
are currently used in routine clinical practice as both a diagnostic
tool and to guide treatment.
TEG (trademark of Haemonetics Cor-
poration, USA: www.haemonetics.com) and ROTEM (trademark
of TEM International GmbH: www.rotem.de) work by measur-
ing shear elastic modulus during clot formation and subsequent
fibrinolysis. In both tests the whole blood sample is placed in a
sample cup or ‘cuvette’ into which a cylindrical pin is immersed,
leaving a small gap between the bottom of the pin and the base
of the cuvette. The subsequent movement of the blood (designed
to emulate sluggish circulation) is where the main difference lies
between the two methods. When the sample blood begins to clot
(i.e. fibrin begins to form, measured as clotting time or ‘time to
clot’), themovement of the pin becomes restricted with increasing
firmness and this kinetic is transferred to the machinery of the
TEG or ROTEM unit.
The next stage of the coagulation process is platelet aggregation,
where platelets build in the blood vessel walls at the site of injury.
Fibrin binds to the platelets, which then form a stronger clot,
measured by both TEG and ROTEM in shear elasticity units as
‘clot stability’. Eventually lysis - or clot break down - is measured,
and a graphic is produced that represents haemostatic performance
at all these stages: clotting time, clot formation, clot stability and
lysis (see detailed description in Appendix 1).
Whilst both TEG and ROTEM measure clotting time, clot for-
mation, clot strengthening, amplitude of clot, maximum strength
of clot, and clot lysis, they use slightly different terms or lettering
to designate these features. These differences are detailed in Table
1.
Rationale
This systematic review forms part of the evidence for a wider
NIHR-funded research programme (’Traumatic Coagulopathy &
Massive Transfusion - Improving Outcomes & Saving Blood’ RP-
PG-0407-10036), which aims to improve outcomes for severely
injured bleeding trauma patients. This programme is designed
around the principle that early identification of patients who
present with a TIC and effective, directed therapy will lead to im-
proved outcomes, reduced complications and rationalised trans-
fusions. In addition, these initiatives will result in reduced costs to
the National Health Service (NHS), and a reduced logistical bur-
den to military and humanitarian organisations (such as the Red
Cross) within austere combat environments. These tests, however,
require proper evaluation. Test accuracy studies have been con-
ducted amongst evaluations thus far and should be systematically
reviewed.
To complement this review we are also conducting a systematic
review of prognosis studies linking measures from TEG/ROTEM
with patient outcome (Hunt 2014).
O B J E C T I V E S
The objective was to determine the diagnostic accuracy of throm-
boelastography and rotational thromboelastometry for TIC in
adult trauma patients with bleeding, using a reference standard
of Prothrombin Time ratio and/or the International Normalized
Ratio.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included all cross-sectional studies investigating the diagnos-
tic test accuracy of TEG or ROTEM in patients with clinically
suspected TIC. We would have included case-control studies due
to the small number of cross-sectional studies retrieved, but we
found none.
Participants
We included all studies involving adult trauma patients with clin-
ically suspected TIC in both military and civilian settings.
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Index tests
This review focused on two global tests of haemostatic function;
TEG (thromboelastography - trademark of theHaemonetics Cor-
poration, USA) and ROTEM (rotational thromboelastometry -
trademark of TEM International GmbH). Thresholds are indi-
cated in Table 1.
Target conditions
The target conditionwasTICdefinedby standard clotting times of
prothrombin time ratio (PTr) and international normalized ratio
(INR).
Reference standards
In the absence of embedded clinical consensus, we used a coag-
ulopathic range based on PTr/INR; the lower limit of the coag-
ulopathic range being a PTr/INR reading of 1.2 or greater (Frith
2010), and the higher limit of the coagulopathic range being a
PTr/INR reading of 1.5 or greater (Stainsby 2006). There is no
upper threshold: anyone with a PTr/INR count of above 1.2, or
above 1.5, is considered coagulopathic. These figures were reached
through discussion by the report authors, including experts in
haematology and trauma medicine.
PTr differs from INR, although the final numbers may be the
same. The PTr calculated varies according to local thresholds and
separate batches of different manufacturers’ reagent involved in
conducting the prothrombin time test. In an effort to standardise
this measurement, the INR is calculated as the ratio of a patient’s
PTr compared to a mean normal PTr (calculated by determining
the mean of 30 or more patients who are representative of the
local hospital population), computed to the power of the Inter-
national Sensitivity Index (ISI), which is itself calculated by the
manufacturer, to give an indication of how each batch of tissue
factor corresponds to an international reference. The equation for
calculation is shown in Figure 2.
Figure 2. INR equation
Search methods for identification of studies
In order to reduce publication and retrieval bias we did not restrict
our search by language, date or publication status.We used a sen-
sitive search strategy to identify literature relating to the index tests
for this review. This strategy was not limited by language but was
limited by date to 1970 to current and to ‘human only’ popula-
tions. The search strategy was modified to increase sensitivity after
the protocol had been published. This amendment is recorded in
Appendix 2.
Electronic searches
We searched the following bibliographic sources:
1. The Cochrane Library (all databases; 4 March 2013);
2. Ovid MEDLINE(R), Ovid MEDLINE(R) In-Process &
Other Non-Indexed Citations, Ovid MEDLINE(R) Daily and
Ovid OLDMEDLINE(R) (1946 to 4 March 2013);
3. Embase Classic and Embase (OvidSP) (1947 to 4 March
2013);
4. PsycINFO (OvidSP) (1806 to February Week 4 2013);
5. CINAHL (EBSCO Host) (1981 to 4 March 2013);
6. ISI Web of Science: Science Citation Index Expanded (SCI-
EXPANDED) (1970 to March 2013);
7. ISI Web of Science: Conference Proceedings Citation
Index-Science (CPCI-S) (1990 to March 2013);
8. Prospero (2011 to March 2013);
9. LILACS (4 March 2013);
10. BIOSIS (1969 to 4 March 2013);
11. British Nursing Index (Proquest) (1994 to 4 March 2013);
12. HMIC (4 March 2013);
13. Transfusion Evidence Library (1980 to 4 March 2013);
14. Centre for Reviews and Dissemination (CRD) (4 March
2013).
The Cochrane Injuries Group Specialised Register was not
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searched for this review as it does not contain diagnostic test ac-
curacy studies.
We searched the following trials registers:
• Current Controlled Trials (http://www.controlled-
trials.com/) (accessed 4 March 2013);
• Clinical Trials.Gov (www.clinicaltrials.gov) (accessed 4
March 2013);
• The World Health Organization (WHO) International
Trials Registry Platform (http://www.who.int/ictrp/en/)
(accessed 4 March 2013).
We searched the following websites (15/03/2012):
• Aggressive Research Intelligence Facility (ARIF) (http://
tinyurl.com/3u9tevp);
• C-EBLM (ww.ifcc.org);
• Cochrane Diagnostic Test Accuracy Working Group (http:/
/srdta.cochrane.org/);
• MEDION database (http://www.mediondatabase.nl);
• Haemonetics Corporation (http://www.haemonetics.com/
en.aspx);
• TEM Innovations GmbH (http://www.rotem.de/site/
index.php).
Searching other resources
We conducted citation chasing on all studies included for full text
screening. Where necessary we attempted to contact authors for
any additional or supporting information.
For further details on the search, including the search strategy,
please see Appendix 2.
Data collection and analysis
Selection of studies
Searches and deduplication were performed by the information
specialist (CC) before transferring the results to HH, CH and ZZ
for screening. All sources were managed using Review Manager
software version 5.2 (RevMan 2012). The inclusion criteria were
based on the Criteria for considering studies for this review. Three
authors (HH, CH and ZZ) made decisions independently on the
inclusion/exclusion of studies, using piloted criteria. Any disagree-
ments were resolved with reference to a fourth experienced author,
although in the event this was not necessary.
Data extraction and management
The reviewer extracted the following data (where available) into a
bespoke data extraction table.
• Author, year of study, year of publication, journal reference.
• Study design and timing of data collection (prospective/
retrospective).
• Study population and participant characteristics (age, sex,
setting - e.g. hospital, region, country, other details given).
• Trauma type:
◦ blunt/penetrating;
◦ traumatic brain injury (TBI)/no TBI;
◦ site of injury.
• Trauma severity as measured by:
◦ Injury Severity Score (ISS);
◦ New ISS (NISS); and
◦ Trauma ISS (TRISS).
• Length of time from injury to admission.
• Percentage receiving massive transfusion (defined as ≥ 10
units packed red blood cells in 24 hours, or the replacement of
an equivalent amount of blood to an entire circulating blood
volume of the patient within 24 hours (Doran 2010)).
• Mean and interquartile range (IQR) number of units of
blood and blood components (fresh frozen plasma, platelets and
cryoprecipitate) transfused.
• Temperature (% hypothermic at 33 degrees or below),
systolic blood pressure (% shocked), and base deficit (% with
hypoperfusion) on admission.
• Duration of bleed at point of testing.
• Reference test used (PTr/INR) and any other measures
taken (of, for example, PT, APTT, fibrinogen level, platelet
count, fibrinogen degradation products).
• Index test used (TEG/ROTEM) and version of device.
• Any details about device reliability.
• When tests were carried out in treatment phase (i.e. pre/
post transfusion, timings).
• Data from the 2 x 2 table will be extracted where presented,
i.e. true positives, false positives, true negatives and false
negatives.
• QUADAS-2 items (see Table 2).
We recorded variability between operators and assay conditions
where available, although this was often not reported in primary
studies. Particular care was required in recording many of these
items (particularly index test and reference standard) due lack of
standardisation. Two authors (HH and CH) piloted the extraction
form using two primary diagnostic studies, with a third author
(NC) in place to resolve disagreements. The data extraction form
was accompanied by a briefing document explaining how it should
be used. Data were extracted by one author (HH) and checked by
a second (CH), with a third author (NC) providing moderation
as required.
Assessment of methodological quality
We carried out quality assessment using a checklist approach to as-
sess the quality of primary studies, on theQUADAS-2 instrument
and in line with advice given in Reitsma 2009. Independently,
we scored each item as ‘yes’, ‘no’ or ‘unclear’ as recommended by
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the Cochrane Handbook for Diagnostic Test Accuracy Reviews
(Deeks 2010). A categorisation of ’unclear’ is generally considered
to be a marker of poor quality, so we took care to account for
the possibility that failing to report an item was reasonable given
the circumstances in which the study was conducted. Results are
presented in the Methodological quality of included studies with
further detail in Table 2.
Statistical analysis and data synthesis
We used Review Manager software (version 5.2) to conduct our
analysis. We analysed the accuracy of TEG and ROTEM com-
pared to the reference standard as detailed in the review protocol
(Hunt 2013), with the intention to consider values greater than
1.2 and greater than 1.5 separately - although insufficient data
were available to render this necessary. Updates may be able to in-
corporate this discrimination if sufficient data are available. Our a
priori commitment to exploring the TEG and ROTEM test type
as a potential source of heterogeneity was unnecessary, as all of
the studies included used ROTEM as their index test. However,
regardless of results it should be noted that ROTEM and TEG are
not interchangeable. Whilst the underlying mechanism of mea-
suring shear elastic modulus is similar, the tests use different clot-
ting activators, different methodology and require different treat-
ment algorithms (Hagemo 2013b; Sankarankutty 2012). There-
fore, TEG and ROTEMwould not have been formally compared.
Results are test accuracy data which form the components of the
2 x 2 table, sensitivity and specificity and their 95% confidence
interval (CI). These results have been tabulated and are presented
according to the different ROTEM sub-measures used in Data
table 1, Data table 2 and Data table 3. These data are also pre-
sented graphically (in forest plots Figure 3, and summary receiver
operating characteristic (ROC) plots Figure 4). A narrative anal-
ysis was conducted with conclusions based on patterns of results.
Quantitative meta-analysis was not appropriate as there were too
few studies to estimate the parameters of meta-analytic models.
Figure 3. Forest plot of tests: ROTEM CA5, ROTEM CA10, ROTEM CA15
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Figure 4. Summary ROC Plot of tests: ROTEM CA5, ROTEM CA10, ROTEM CA15
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Investigations of heterogeneity
There was an insufficient number of studies included in the re-
view for us to conduct formal investigations of heterogeneity. The
approach specified in the protocol is recorded in Appendix 3, and
will be used, should the review be updated in the future.
Sensitivity analyses
As no meta-analysis was conducted, no sensitivity analysis was
required. Should the review be updated in future, we will follow
guidance inChapter 10 of theCochraneHandbook for Systematic
Reviews of Diagnostic Test Accuracy (Macaskill 2010).
Assessment of reporting bias
We did not assess reporting bias because its impact in test accuracy
is unclear and the tools for investigating it are in the early stages
of development.
R E S U L T S
Results of the search
We screened 9013 citations and examined 91 full text articles in
detail to reveal three included studies Rugeri 2007, Woolley 2012
and Davenport 2011a. The characteristics of the included studies
are tabulated in Table 3 and Table 4. The PRISMA study flow
diagram is shown in Figure 5.
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Figure 5. Study flow diagram
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All three included studies used ROTEM as the test of global
haemostatic function, and none used TEG.Whilst there may be a
difference of one or two versions betweenROTEMmodels, funda-
mentally the technology and tests are the same. Of the many mea-
surements that can be made by ROTEM, EXTEM (tissue factor)
clot amplitude (CA) was the focus of the accuracy measurements
in blood samples taken near to the point of admission. However,
these CAs were not measured at a uniform time after the start of
the coagulopathic trace. The time varied from five minutes (A5
or CA5; Davenport 2011a; Woolley 2012), ten minutes (A10 or
CA10; Woolley 2012) and fifteen minutes (A15 or CA15; Rugeri
2007). Concerning the thresholds for the CA measurements, the
two studies using EXTEM CA5 used a threshold of 35 mm or
below (Davenport 2011a), and below a reference range of 32 mm
to 71 mm (Woolley 2012); the study using CA10 used a threshold
of below a reference range of 40 mm to 72 mm (Woolley 2012);
and the study using EXTEM CA15 used a threshold of less than
32 mm (Rugeri 2007).
In accordance with the review inclusion criteria, wemade accuracy
measures in all the included studies relative to a reference standard
of PTr. However in two cases the PTr value was greater than 1.5
(Rugeri 2007; Woolley 2012), and in one case greater than 1.2
(Davenport 2011a). We also examined accuracy relative to other
reference standards defining TIC in the included studies, but none
of the alternatives were used consistently. The need for massive
transfusion (systolic blood pressure less than 90 mmHg, poor re-
sponse to initial fluid infusion and suspicion of ongoing haemor-
rhage) was considered as a marker for coagulopathy by Davenport
2011a. Rugeri 2007 also used an APTT value of more than 1.5 of
control, fibrinogen less than 1 g/L (Fibriquick/Clauss technique),
and platelets less than 50 x 109 L−1 (SE-9500 - Sysmex, Kobe,
Japan) as alternative definitions of coagulopathy. Finally, Woolley
2012 examined accuracy relative to ROTEM EXTEMMaximum
Clot Firmness (MCF) below 40 mm, and this was, in fact, the
main focus of their study.
The three included studies were conducted in the UK (Davenport
2011a), France (Rugeri 2007) and Afghanistan (Woolley 2012), in
both civilian and military trauma settings. The trauma appeared
moderate to severe in all the included studies, and was most severe
in the military setting where there were injuries from improvised
explosive devices and ballistics (Woolley 2012), and least severe in
the UK NHS (Davenport 2011a). As a corollary, the frequency of
TIC (PTr above the defined range) was 8% and 28% in the civilian
settings (Davenport 2011a; Rugeri 2007, respectively), and 51%
in the military setting (Woolley 2012). The studies varied in size
from 300 participants to 90 and 48. The number of patients con-
tributing to the accuracy estimates was complicated, particularly
in the study by Woolley, where there were multiple samples from
individual patients (Woolley 2012). This also complicates what
can be inferred about whether the blood samples were taken close
to the point of admission in all cases (see above).
All studies employed standard test accuracy designs where index
tests and reference standards were applied to naturally occurring
groups of patients presenting to trauma centres. There were no
diagnostic case-control studies. However it is worthy of note that
in no case was the assessment of accuracy the single objective of the
included studies and indeedmay not have been themain objective.
The studies were a mixture of attempts to identify a normal range
in healthy patients (and to compare values in trauma patients)
(Rugeri 2007; Woolley 2012), correlations of usual coagulation
test results with ROTEM values (Rugeri 2007), and exploration
of the threshold for ROTEM results (Davenport 2011a; Rugeri
2007; Woolley 2012).
All three studies declared support from external sources. The
Davenport 2011a study received equipment and materials from
Pentapharm GMbH (manufacturers of ROTEM - Munich, Ger-
many), and two study authors received unrestricted equipment
and materials grants from the manufacturers. Rugeri 2007 stated
that they were grateful to BIODIS (Signes, France) for their sup-
port of the study, but declared no conflicts of interest. Woolley
2012 declared that the work was funded by and formed part of
the Human Dimension and Medical Sciences Domain Research
programme within the UK Ministry of Defence (MoD) Defence
Science and Technology Laboratory (DSTL) Programme Office.
Methodological quality of included studies
This is summarised in the QUADAS-2 tables with further infor-
mation provided in Table 2. A ’Risk of bias and applicability con-
cerns’ graph is presented in Figure 6.
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Figure 6. Risk of bias and applicability concerns graph: review authors’ judgements about each domain
presented as percentages across included studies
Concerning risk of bias, we felt the risk to be low across the in-
cluded studies for the patient and flow and timing domains. There
was some concern regarding timing domains arising frommultiple
samples being taken from the same patient in the Woolley 2012
study, but this was not felt to be a major problem.
The risk of bias for the index test domain for the trials was ei-
ther high or unclear, and arose, principally, from failure to pre-
specify the threshold. Davenport 2011a based their threshold on
maximum separation between normal and acute traumatic coag-
ulopathy patients. The origin of the threshold from the study by
Rugeri 2007 appears to have been based on results of correlation
between ROTEM results and standard measures of coagulation.
Woolley 2012 created a reference range for Camp Bastion, with
results based on 50 uninjured volunteers (existing members of the
Emergency Blood Donor Panel). In summary, only Woolley 2012
seems to have generated a threshold external to the participants
to generate the accuracy estimations, and even this could be criti-
cised, as it relies on test values lying outside a normal range.
The risk of bias for the reference standard domain was also high.
This principally rose from concern that PTr is not a completely
robust measure to define coagulopathy, even though, pragmati-
cally, it is the most consistently used definition. Our view was that
it could only be relied on if there was some examination of dis-
crepant samples, particularly to explore the possibility that some
’true’ cases of TIC had normal PT, which, anecdotally, is claimed
to occur. There were no such discrepant analyses.
Concerning applicability, we have no concerns as far as the patient
population is concerned, though we have concerns about the in-
dex test domain. Although CA as a ROTEM measure is clearly
relevant to the review question, the concern arose because it was
unclear why this measure had been chosen over other measures.
Furthermore, there is a need to wait for at least 10 and 15 minutes
to obtain a result for CA10 and CA15, which might limit their
usefulness relative to measures that can be obtained earlier in the
ROTEM trace. There was a complete absence of information for
the other commonly used device, TEG.
Findings
See Characteristics of included studies; Characteristics of excluded
studies; Table 3; Table 4.
There were insufficient included studies examining each of the
three ROTEM CAs at 5, 10 and 15 minutes to make the meta-
analysis and investigation of heterogeneity valid. The results of
the included studies are thus reported narratively and illustrated
by a forest plot (Figure 3), with results plotted on the ROC plane
(Figure 4).
For CA5 the accuracy results were sensitivity 70% (95%CI 47,87)
and specificity 86% (95% CI 82, 90) for one study (Davenport
2011a), and sensitivity 96% (95%CI 88,100) and specificity 58%
(95% CI 44,72) for the other (Woolley 2012).
For CA10 the accuracy results were sensitivity 100% (95% CI
94,100) and specificity 70% (95% CI 56,82) (Woolley 2012).
For CA15 the accuracy results were sensitivity 88% (95% CI
69,97) and specificity 100% (95% CI 94,100) (Rugeri 2007).
None of the included studies mentioned uninterpretable ROTEM
study results.
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Summary of findings
What is the test accuracy of thromboelastography (TEG) and rotational thromboelastometry (ROTEM) for trauma induced coagulopathy (TIC) in adult trauma patients with bleeding?
Patients Adult trauma patients with bleeding at risk of TIC
Prior testing None
Setting Hospital; civilian or military
Index tests Tests of global haemostatic function especially thromboelastography (TEG) and rotational thromboelastometry (ROTEM)
Any device output measure considered
Reference standard • Prothrombin ratio or International Normailsed ratio 1.2 or greater
• Prothrombin ratio or International Normailsed ratio 1.5 or greater
Study design Cross-sectional or case-control test accuracy studies; all included studies were cross-sectional






Risk of bias Implications
ROTEM EXTEM Clot ampli-
tude 5 minutes (CA5)
409 (2) Davenport 2011a: 70% (47,
87)
Woolley 2012: 96% (88,100)
Davenport 2011a: 86% (82,
90)
Woolley 2012: 58% (44,72)
High Accuracy estimates potentially misleading
ROTEM EXTEM Clot ampli-
tude 10 minutes (CA10)
109 (1) 100% (94,100) 70% (56,82) High Accuracy estimates potentially misleading
ROTEM EXTEM Clot ampli-
tude 15 minutes (CA15)
88 (1) 88% (69,97) 100% (94,100) High Accuracy estimates potentially misleading























































































































































D I S C U S S I O N
Summary of main results
There is no evidence for the accuracy of TEG and very little evi-
dence for the accuracy of ROTEM. The latter is limited to infor-
mation on the accuracy of CA at 5, 10 and 15 minutes, as opposed
to the many other features of the ROTEM trace that might be
used. Furthermore, the value of the accuracy estimates for CA are
considerably undermined by the number of studies (two for CA5
and one each for CA10 and CA15) and concerns about risk of bias
arising from considerations about the index test and the reference
standard.
Strengths and weaknesses of the review
The review was conducted using a pre-specified protocol designed
by a large multi-disciplinary team with expertise in the condition,
the test and the evaluationmethodology. There were no departures
from this protocol, bar failure to use meta-analysis because of
an insufficient number of included studies. We conducted a very
comprehensive search that was screened in triplicate.We were able
to obtain additional information from many study investigators
because of the strong links many of the review team have with
researchers in the field. This gave us insight that studies rarely,
however, address accuracy alone and are frequently undertaken
as one small component of wider evaluations, opening the risk
of overlooking accuracy results. Those review authors who were
members of the investigating teams of any included studies were
not involved in the quality appraisal of their own study.
Publication bias is an ever present threat that, despite the com-
prehensive search undertaken for this review, is difficult to guard
against completely. The nature of publication bias in test accuracy
studies is still not completely clear. Also the very limited number
of included studies, and the inability to conclude definitively from
them, restricts the potential importance of possible publication
bias in this review.
The main limitation of the review is the very limited number of
included studies and the possibility of bias in these. Together these
conspire to leave the accuracy of global measures of haemostatic
function virtually unknown at present. This raises the question of
whether the absence of this information is important and, if so,
how evidence on it should be obtained in future. It also prompts
questions concerning whether other types of evaluation of TEG
and ROTEM, beyond accuracy, should be examined in parallel or
in preference to accuracy data. Both of these issues are considered
in further detail in recommendations for research below.
Applicability of findings to the review question
Although the three included studies match the review question,
they only cover a fraction of the issues needing to be addressed
to fully examine the accuracy of global measures of haemostatic
function. There are no evaluations of TEG and the evaluations of
ROTEM are restricted to measures of CA at different points in
time.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
We found no evidence on the accuracy of thromboelastography
(TEG) and very little evidence on the accuracy of rotational throm-
boelastometry (ROTEM).The value of accuracy estimates are con-
siderably undermined by the small number of included studies,
and concerns about risk of bias relating to the index test and the
reference standard. We are therefore unable to offer advice on the
use of global measures of haemostatic function for trauma based
on the evidence on test accuracy identified in this systematic re-
view. This evidence strongly suggests that at present these tests
should only be used for research.
Implications for research
Based on the findings outlined above, the evidence strongly sug-
gests that currently these tests should only be used for research.
We consider below what this research could be.
Which test?
The review emphasises that it is insufficient to define the index
test solely in terms of the device.
Both ROTEM and TEG offer a number of measures: time to ini-
tiate clotting; time of clot formation; alpha angle; clot amplitude;
maximum strength of clot; time to maximum clot strength; time
to lysis of different degrees. These are illustrated in Figure 7. Fur-
thermore the protocol for initiating clotting also needs to be spec-
ified e.g. INTEM, EXTEM or FIBTEM in the case of ROTEM.
Greater clarity is needed on which of the measures is most robust
and which is most relevant for specific clinical tasks; there may
be more than one. In the context of trauma, a measure that is
available early in the trace would seem to be the most valuable.
It may be, however, that there is a trade-off, where timeliness is
achieved at the expense of accuracy. This does not appear to have
been investigated, although it may be that this has been established
in applications beyond trauma. Even if this is the case there may
still be a need to repeat the exercise in trauma patients.
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Figure 7. Viscoelastic haemostatic assays terminology and parametersα, alpha angle; AUC, area under the
curve; CFT, clot formation time; CL (t), clot lysis (at time t); CT, clot time; k, rate of clot formation; LY (t),
lysis (at time t); MA, maximum amplitude; MAXV, maximum velocity; MAXV-t, time to maximum velocity;
MCF, maximum clot firmness; MCF-t, time to maximum clot firmness; ML, maximum lysis; r, time to clot
initiation; ROTEM, Rotational Thromboelastogram; RT, reaction time; TEG, Thromboelastograph; TMA, time
to maximum amplitude; ’-’; no equivalent parameter.Reproduced by kind permission of Dr Roger Luddington,
Addenbrooke’s Hospital, UK
What test threshold?
Given the lack of clarity about the specific test measures most
likely to be helpful in diagnosing coagulopathy, it is not surpris-
ing that the thresholds that define when the disease is present and
absent still appear to be unclear. Once the precise measures have
been identified, however, it is important that these thresholds are
derived from a data-set independent of that used to measure the
accuracy. This principle did not seem to be widely appreciated
in the included studies where the same data-sets were used. Fur-
thermore, the reference ranges employed in the included studies,
although they provided a useful starting point, may not be suffi-
cient to define thresholds, as they assume a complete separation
between non-disease and disease, which is unusual.
Is test accuracy important?
Given the uncertainty about the reference standard it may be rea-
sonable to question the value of accuracy of data in evaluating
global measures of haemostatic function. However, even with the
concerns about pro-thrombin time ratio (PTr) either greater than
1.2 or greater than 1.5 as a reference standard, further steps could
have been taken in the accuracy studies we included to improve
their value.
• Investigators could have examined discrepant samples,
particularly ’false positives’ to consider whether by using all
available clinical data there was evidence that ROTEM measures
gave a better indication of the presence of coagulopathy than the
current reference standard. We encountered studies that did this
for individual cases, but not in the context of an accuracy study.
• Investigators could have looked at PTr alongside other
markers of coagulopathy, creating a composite reference standard
definition consisting for instance of high PTr or low fibrinogen
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levels or low platelets.
• Investigators could have used quasi-clinical definitions of
coagulopathy incorporating features such as uncontrollable
bleeding, need for transfusion or massive transfusion.
Investigators in the included accuracy studies indicated that they
had considered such approaches, but they appear to have lacked
confidence to apply them consistently and in combination.
In time it may be reasonable to use complete data from a coagu-
lation trace to validate and assess the accuracy of single early trace
measures, however, this requires authoritative demonstration of
the accuracy of the complete trace data, which the current evidence
base does not provide. Given all of these considerations, further
research on test accuracy is justified.
Irrespective of the nature of the reference standard in future accu-
racy studies, attention must be paid to minimising bias through
good conduct and reporting adhering to the STARD criteria
(Bossuyt 2003).
Are other test evaluations needed?
There is a case that the objections to an imperfect reference stan-
dard may not be completely overcome, or that better accuracy
studies will leave aspects of evaluation uncovered.
There are certainly other test designs that might help to under-
stand the value of a new test, particularly one that appears to offer
advantages over current reference standards. This is the case for
global measures of haemostatic function, because it is clear that
they offer the ability to examine the whole coagulation process
rather than just specific components of it.
The link between test result and outcome is potentially very in-
formative. Such prediction or prognosis studies are particularly
achievable in this scenario because patients succumb to coagulopa-
thy or survive it over a short time interval. In addition, the current
impact of alternative treatments may not be pronounced because
optimal treatment strategies are not clearly identified. It is impor-
tant to review prognosis studies and a protocol for one has just
been registered on PROSPERO by this review group. Depending
on its results, further studies of prognosis may be helpful.
Ultimately evaluation may require interventional studies in which
the effect on patient outcomes is compared in patients using TEG/
ROTEM informed management with those using normal prac-
tice. Randomised trials of this type have been undertaken for the
use of TEG/ROTEM in cardiac surgery and liver transplantation,
and these have been the subject of a Cochrane Review (Afshari
2011b). It should be noted that the Afshari 2011b review included
eight trials of routine cardiac surgery with only one trial of liver
transplantation, although the review title does not make this ex-
plicit. Although the results from studies in routine cardiac surgery
are not generalisable to the use of TEG/ROTEM in trauma, they
do illustrate the feasibility of interventional studies. At least one
controlled clinical trial appears to have been conducted (Messen-
ger 2011). However, the appropriateness of such trials where there
appears to be lack of clarity about the specific TEG and ROTEM
measures to use, and how results in particular ranges from these
measures should influence management, is debatable.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Davenport 2011a
Study characteristics
Patient sampling See study characteristics in Table 3 and Table 4 and quality appraisal details in Table 2
Patient characteristics and set-
ting
See study characteristics in Table 3 and Table 4 and quality appraisal details in Table 2
Index tests See study characteristics in Table 3 and Table 4 and quality appraisal details in Table 2
Target condition and reference
standard(s)
See study characteristics in Table 3 and Table 4 and quality appraisal details in Table 2




Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
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Davenport 2011a (Continued)
Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Were exclusions accounted for? Yes
Rugeri 2007
Study characteristics
Patient sampling See study characteristics in Table 3 and Table 4 and quality appraisal details in Table 2
Patient characteristics and set-
ting
See study characteristics in Table 3 and Table 4 and quality appraisal details in Table 2
Index tests See study characteristics in Table 3 and Table 4 and quality appraisal details in Table 2
Target condition and reference
standard(s)
See study characteristics in Table 3 and Table 4 and quality appraisal details in Table 2
Flow and timing See study characteristics in Table 3 and Table 4 and quality appraisal details in Table 2
Comparative
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Rugeri 2007 (Continued)
Notes Published study reported Negative Predictive Value (NPV) = 99, but calculated in this report using
RevMan software NPV = 95 [figure used in analysis]. Study author could not explain the difference
and raw data was no longer available
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes




DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes




DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low
DOMAIN 4: Flow and Timing
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Rugeri 2007 (Continued)
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Were exclusions accounted for? Yes
Woolley 2012
Study characteristics
Patient sampling See study characteristics in Table 3 and Table 4 and quality appraisal details in Table 2
Patient characteristics and set-
ting
See study characteristics in Table 3 and Table 4 and quality appraisal details in Table 2
Index tests See study characteristics in Table 3 and Table 4 and quality appraisal details in Table 2
Target condition and reference
standard(s)
See study characteristics in Table 3 and Table 4 and quality appraisal details in Table 2




Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
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Woolley 2012 (Continued)
Low
DOMAIN 2: Index Test All tests
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear




DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Were exclusions accounted for? Yes
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Afshari 2011a Not a primary study
Afshari 2011b Not a primary study
Anonymous 2007 Unobtainable
Anonymous 2008 Unobtainable
Avikainen 1977 Not a DTA study
Blackbourne 2012 Not a primary study
Cap 2011 Outcome not in line with inclusion criteria
Carroll 2009 Outcome not in line with inclusion criteria
Chandler 2010 Intervention not in line with inclusion criteria
Cheng 2009 Outcome not in line with inclusion criteria
Cotton 2011 Not a DTA study
Cotton 2012a Condition not in line with inclusion criteria
Cotton 2012b Not DTA study
Craft 2008 Not a DTA study
Curry 2011 Not a DTA study
Davenport 2009 Not a DTA study
Davenport 2011b Not a DTA study
David 2011 Not a primary study
Differding 2011 Outcome not in line with inclusion criteria
Ettinger 1970 Population not in line with inclusion criteria
Floccard 2012 Intervention not in line with inclusion criteria
Franschman 2012 Intervention not in line with inclusion criteria
Frink 2009 Not a primary study
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(Continued)
Hagemo 2013a Not a primary study
Hagemo 2013b Reference standard not in line with inclusion criteria
Jambor 2009 Not primary study
Jeger 2009 Not a DTA study
Jeger 2010 Not a primary study
Jeger 2011a Abstract - author contacted
Jeger 2011b Duplicate of Jeger 2011a
Jeger 2012 Not a DTA study (FT of Jeger 2011a)
Kashuk 2010 Abstract - author contacted
Kashuk 2012 Not DTA study (FT of Kashuk 2010)
Kaufmann 1995 Abstract - author contacted
McCann 2011 Not a DTA study
Messenger 2011 Not a DTA study
Nystrup 2011 Not a DTA study
Ostrowski 2011 Not a DTA study
Ostrowski 2012a Not a DTA study
Ostrowski 2012b Not a DTA study
Park 2008 Not a DTA study
Park 2009 Outcome not in line with inclusion criteria
Pezold 2012 Outcome not in line with inclusion criteria
Plotkin 2008 Outcome not in line with inclusion criteria
Raza 2011a Outcome not in line with inclusion criteria
Raza 2011b Outcome not in line with inclusion criteria
Raza 2013 Outcome not in line with inclusion criteria
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(Continued)
Rizoli 2011 Outcome not in line with inclusion criteria
Rourke 2012 Outcome not in line with inclusion criteria
Schochl 2005 Unobtainable
Schochl 2007 Abstract of Schochl 2009 - not a DTA study
Schochl 2009 Not a DTA study
Schochl 2011a Not a DTA study
Schochl 2011b Not a DTA study
Schochl 2011c Not a DTA study
Schochl 2012a Not a DTA study
Schochl 2012b Not a DTA study
Schreiber 2005 Not a DTA study
Schreiber 2009 Not a DTA study
Shah 2012 Not a DTA study
Sharma 2010 Population not in line with inclusion criteria
Sixta 2013 Not a DTA study
Solomon 2011 Not a DTA study
Spoors 2011 Not a DTA study
Tanaka 2012 Not a DTA study
Tapia 2013 Not a DTA study
Theusinger 2011 Not a DTA study
Theusinger 2013 Not a DTA study
Watters 2010 Outcome not in line with inclusion criteria
Weiss 2011 Not a DTA study
Windelov 2011 Not a DTA study
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(Continued)
Wohlauer 2012 Not a DTA study
Woolley 2010 Not a DTA study
Abbreviation
FT: full text
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D A T A
Presented below are all the data for all of the tests entered into the review.






1 ROTEM CA5 2 409
2 ROTEM CA10 1 109
3 ROTEM CA15 1 88
Test 1. ROTEM CA5.
Review: Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) for trauma induced coagulopathy in adult trauma patients with bleeding
Test: 1 ROTEM CA5
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Davenport 2011a 16 38 7 239 0.70 [ 0.47, 0.87 ] 0.86 [ 0.82, 0.90 ]
Woolley 2012 54 22 2 31 0.96 [ 0.88, 1.00 ] 0.58 [ 0.44, 0.72 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 2. ROTEM CA10.
Review: Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) for trauma induced coagulopathy in adult trauma patients with bleeding
Test: 2 ROTEM CA10
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Woolley 2012 56 16 0 37 1.00 [ 0.94, 1.00 ] 0.70 [ 0.56, 0.82 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 3. ROTEM CA15.
Review: Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) for trauma induced coagulopathy in adult trauma patients with bleeding
Test: 3 ROTEM CA15
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Rugeri 2007 22 0 3 63 0.88 [ 0.69, 0.97 ] 1.00 [ 0.94, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
A D D I T I O N A L T A B L E S
Table 1. Normal reference values for ROTEM and TEG
TEG ROTEM
Clotting time (period to 2 mm amplitude) R (reaction time)
N (whole blood) 4 to 8 min
N (Cit, kaolin) 3 to 8 min
CT (clotting time)
N (Cit, INTEM) 137 to 246 s
N (Cit, EXTEM) 42 to 74 s
Clot kinetics (period from 2 to 20 mm am-
plitude)
K (kinetics)
N (WB) 1 to 4 min
N (Cit, kaolin) 1 to 3 min
CFT (clot formation time)
N (Cit, INTEM) 40 to 100 s
N (Cit, EXTEM) 46 to 148 s
Alpha angle (clot strengthening) α (slope between r and k)
N (WB) 47° to 74°
N (Cit, kaolin) 55° to 78°
α (slope of tangent at 2 mm amplitude)
N (Cit, INTEM) 71° to 82°
N (Cit, EXTEM) 63° to 81°
Amplitude (at set time) A or CA A or CA
Maximum strength MA (maximum amplitude)
N (WB) 55 to 73 mm
N (Cit, kaolin) 51 to 69 mm
MCF (maximum clot firmness)
N (Cit, INTEM) 52 to 72 mm
N (Cit, EXTEM) 49 to 71 mm
N (Cit, FIBTEM) 9 to 25 mm
Lysis (at fixed time) CL30, CL60 LY30, LY60
TEG: N = normal values for kaolin-activated TEG in native whole blood (WB) or citrated and recalcified blood samples (Cit)
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ROTEM: N = normal values for contact (partial thromboplastin phospholipids, INTEM), tissue factor (EXTEM) and tissue factor
plus platelet inhibitor cytochalasin D (FIBTEM) activated citrated and recalcified blood samples
Reference values depend on reference population, blood sampling technique, other preanalytical factors, and coagulation activator
(Ganter 2008)
min: minute(s)
Table 2. Quality appraisal (using QUADAS-2)
QUADAS-2 quality appraisal Included studies
Davenport 2011a Rugeri 2007 Woolley 2012
Summary patient domain
Was a consecutive or random
sample of patients enrolled?
Yes
Near consecutive, bar exclu-
sions
Yes
Clear statement that patients
were consecutive. p 290 col 1
line 10
Unclear
Lack of clarity regarding the
proportion of T1 or T2 casual-
ties over the study period for the
whole population, and also how
the sub-population that con-
tributed to the accuracy study
were chosen
Was case control study design
avoided?
Yes Yes
Could be confusion about de-
termination of normal values
for ROTEM from healthy vol-
unteers
Yes
Could be confusion about the
role of the samples taken from
the 50 uninjured control sub-
jects
Did the study avoid inappro-
priate exclusions?
Yes
Several exclusion criteria, these
all seem reasonable
Yes
Minimal exclusions; 2 out of 90
Yes
Exclusions not mentioned
Risk of bias overall? No No
Is there a concern that the in-
cluded patients do not match
the review question?
Concern: low Concern: low Concern: low
Index test domain
Were the index test results in-
terpreted without knowledge
of the results of the reference
standard?
Unclear
The relative objectivity of both
the ROTEM measure and the
reference standard was judged
to reduce the importance of this
issue
Yes
Clear statement that clinicians
were not informed of ROTEM
results p 291 col 1 line 3
Unclear
No clear statement. The relative
objectivity of both the ROTEM
measure and the reference stan-
dard was judged to reduce the
importance of this issue
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Table 2. Quality appraisal (using QUADAS-2) (Continued)
If a threshold was used was it
pre-specified?
No
Clear statement that choice of
ROTEM measure and thresh-
old were chosen because “there
was good separation of normal
and ATC curves at this time
point” p 2655 col 3 para 6
No
Thresholds were derived from
a normal range in healthy sub-
jects measured in the study.
This is less of a problem than
failure to pre-specify the exact
ROTEM measure. This choice
seems to have been largelymade
on the basis of performance
Unclear
Some pre-statement for prefer-
ence for measure as CA5 and
CA10. Reasons why this was
chosen over other possible early
values such as clotting time, clot
formation time or alpha angle
were not provided. The thresh-
old for CA5 and CA10 was not
pre-specified, but appeared to
be derived from independently
measured normal values (Table
1 p 595)
Risk of bias overall: could the
conduct or interpretation of
the index test have introduced
bias?
Yes
The failure to pre-specify was




is a positive feature that was not
present in other studies, the fail-
ure to pre-specify was consid-
ered to represent a major threat
to validity
Unclear
As for the other included stud-
ies there is a risk of bias asso-
ciated with failure to pre-spec-
ify measure and threshold, but
this was thought to be less than
in the other two included stud-
ies, and was hencemarkedRisk:
unclear rather than Risk: yes
Is there a concern that the in-
dex test, its conduct or inter-
pretation differ from the re-
view question?
Concern: unclear
There is clarity about the test
apparatus. There is less clarity
about whether the exact mea-
sure and threshold are those that
would be used in standard prac-
tice, both because these were
not pre-specified and because
standard practice is not estab-
lished
Concern: high
There is clarity about the test
apparatus. There is less clarity
about whether the exact mea-
sure and threshold are those that
would be used in standard prac-
tice, both because these were
not pre-specified and because
standard practice is not estab-
lished
Concern: unclear
There is clarity about the test
apparatus. There is less clarity
about whether the exact mea-
sure and threshold are those that
would be used in standard prac-
tice, both because these were
not pre-specified and because
standard practice is not estab-
lished
Reference standard domain
Is the reference standard likely
to correctly classify the target
condition?
No
There are concerns that pro-
longed prothrombin time may
not capture all cases of coagu-
lopathy, even though it is the
most established of the mea-
sures of coagulopathy
No
There are concerns that pro-
longed prothrombin time may
not capture all cases of coagu-
lopathy, even though it is the
most established of the mea-
sures of coagulopathy
No
There are concerns that pro-
longed prothrombin time may
not capture all cases of coagu-
lopathy, even though it is the
most established of the mea-
sures of coagulopathy
Were the reference standard
test results interpreted with-
out knowledge of the results of
the index test?
Unclear
No clear statement. The relative
objectivity of both the ROTEM
measure and the reference stan-
Yes
Clear statement that clinicians
were not informed of ROTEM
results p 291 col 1 line 3
Unclear
No clear statement. The relative
objectivity of both the ROTEM
measure and the reference stan-
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Table 2. Quality appraisal (using QUADAS-2) (Continued)
dard was judged to reduce the
importance of this issue
dard was judged to reduce the
importance of this issue
Risk of bias overall? Yes
Reassurance about this possibil-
ity could have been provided if
discrepant samples had been ex-
amined. This was not done
Yes
Reassurance about his possibil-
ity could have been provided if
discrepant samples had been ex-
amined. This was not done
Yes
Reassurance about his possibil-
ity could have been provided if
discrepant samples had been ex-
amined. This was not done
Is there a concern that the tar-
get condition as defined by the
reference standard does not
match the review question?
Concern: low
The reference standard matches
the review question. There are
however noted concerns about
the risk of bias arising from im-
perfection in the reference stan-
dard, particularly where careful
analysis of the discrepant sam-
ples (especially false positives)
was not carried out
Concern: low
The reference standard matches
the review question. There are
however noted concerns about
the risk of bias arising from im-
perfection in the reference stan-
dard, particularly where careful
analysis of the discrepant sam-
ples (especially false positives)
was not carried out
Concern: low
The reference standard matches
the review question. There are
however noted concerns about
the risk of bias arising from im-
perfection in the reference stan-
dard, particularly where careful
analysis of the discrepant sam-
ples (especially false positives)
was not carried out
Flow and timing domain
Was there an appropriate in-
terval between index test and
reference standard?
Yes
Clear evidence that ROTEM
and PT done on same sample.
Yes
Reasonable evidence




that ROTEM and PT done on
same sample
Did all patients receive a ref-
erence standard?
Yes Yes Yes
Did all patients receive the
same reference standard?
Yes Yes Yes
Were all patients included in
the analysis?
Yes Yes Yes
Risk of bias overall? No No No
Other issues - Multiple samples seem to have
been taken from each patient,
but seems reasonably clear that
only the samples at admission
(H0) were used in the analysis
Lack of clarity about whether
some samples came from the
same patient
Abbreviations
CA5: clot amplitude at 5 minutes
CA10: clot amplitude at 10 minutes
col: column
H0: hospital/ emergency room admission
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T1: triaged casualty group 1 - immediate or urgent clinical problems requiring full trauma team activation (as T2 below).
T2: triaged casualty group 2 - immediate or urgent clinical problems requiring full trauma team activation (as T1 above).
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ISS: Injury Severity Score
iv: intravascular
M: male
NISS: New Injury Severity Score
SD: standard deviation
TBI: traumatic brain injury
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Table 4. Characteristics of studies - test details (Continued)
responding to


































APTT: activated partial thromboplastin time
CA5: clot amplitude at 5 minutes
CA10: clot amplitude at 10 minutes
CA15: clot amplitude at 15 minutes
EXTEM: tissue factor activated citrated and recalcified blood sample
FIBTEM: tissue factor plus platelet inhibitor cytochalasin D activated citrated and recalcified blood samples
INR: International Normalized Ratio
PT: prothrombin time
PTr: pro-thrombin time ratio
ROTEM: rotational thromboelastometry
SD: standard deviation
STARTEM: a liquid system reagent for recalcifying citrated blood or plasma
TEG: thromboelastography
A P P E N D I C E S
Appendix 1. TEG and ROTEM equivalent methods
Clotting time
In TEG, clotting time is measured as R (reaction time), N (whole blood; normal values for kaolin activated TEG in whole blood) and
N (Cit, kaolin; normal values for kaolin activated TEG in citrated and recalcified blood). In ROTEM, clotting time is measured as
CT (clotting time), N (Cit, INTEM; normal values for contact) and N (Cit, EXTEM; normal values for tissue factor).
Clot formation
Clot formation is the time from the start of clot formation until the clot firmness (or strength) reaches an arbitrary pre-defined value
(in both ROTEM and TEG this is 20 mm firmness). Clot formation is measured in TEG as K (kinetics) and - as above - N (whole
blood) and N (Cit, kaolin). In ROTEM, CFT (clot formation time) is measured as before as N (Cit, INTEM) and N (Cit, EXTEM).
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Alpha angle
This denotes the angle of the curve during initial clot formation and is a measure of the rapidity of fibrin polymerisation. The alpha
angle in TEG is defined as the slope between R and K and in ROTEM is the slope of tangent at 2 mm amplitude. Again, both tests
give the alpha angle as N (whole blood) and N (Cit, kaolin) for TEG and N (Cit, INTEM) and N (Cit, EXTEM) for ROTEM.
Amplitude of clot/clot amplitude
Amplitude of clot (’CA’ or ‘A’) is given at set times in both tests.
Maximum clot firmness
The maximum strength of the clot is measured in TEG as maximum amplitude (MA) and in ROTEM as maximum clot firmness
(MCF), and both tests give this measurement both as N (whole blood) and N (Cit, kaolin) for TEG and N (Cit, INTEM) and N (Cit,
EXTEM) for ROTEM - although ROTEM also reports tissue factor plus platelet inhibitor cytochalasin D (Cit, FIBTEM).
Clot lysis
Both tests give readings for clot lysis (CL in TEG, e.g. CL30, CL60; and LY in ROTEM, e.g. LY30, LY60).
Appendix 2. Search strategies
Literature searching
A line in the search strategy was altered between publication of the protocol and the searches being run. A truncation marker was moved
to increase the sensitivity of the search, in order to account for thromboelastometry if it was expressed as thrombelasto-metry/-graphy.
Previous line: (thromboelastom$ or thrombelastom$ or (thromb$ adj2 elastom$) or (rotational adj2 thrombelast) or ROTEM or tem
international).mp.
New line: (thromboelasto$ or thrombelasto$ or (thromb$ adj2 elastom$) or (rotational adj2 thrombelast) or ROTEM or tem interna-
tional).mp.
All strategies were checked by CC and HH.
The Cochrane Library
Host: http://www.thecochranelibrary.com/view/0/index.html
Data Parameters: CDSR Issue 2 of 12 (Feb 2013); CENTRAL Issue 1 of 12 January 2013; DARE Issue 1 of 4 Jan 2013; Methods
Issue 1 of 4, Jan 2013; HTA Issue 1 of 4 Jan 2013; NHS EEDS Issue 1 of 4 Jan 2013
Strategy:
#1 MeSH descriptor: [Thrombelastography] explode all trees 141
#2 (Thrombelastogra* or Thromboelastogra* or (thromb* near/3 elastogra*) or TEG or haemoscope or haemonetics) 351
#3 (thromboelasto* or thrombelasto* or (thromb* near/3 elastom*) or (rotational near/3 thrombelast) or ROTEM or “tem interna-
tional”) 273
#4 #1 or #2 or #3 from 1970 368
Hits: 368 (CDSR: 17; DARE: 3; CENTRAL: 339; Methods: 1; HTA: 3; NHS EEDS: 5)
MEDLINE (Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid MEDLINE(R))
Strategy:
41Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) for trauma
induced coagulopathy in adult trauma patients with bleeding (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
# Searches Results
1 (Thrombelastogra$ or Thromboelastogra$ or (thromb$ adj2
elastogra$) or TEG or haemoscope or haemonetics).mp
4711
2 Thrombelastography/ 3190
3 (thromboelasto$ or thrombelasto$ or (thromb$ adj2 elastom$)
or (rotational adj2 thrombelast) or ROTEM or “tem interna-
tional”).mp
4174
4 1 or 2 or 3 4832
5 exp animals/ not humans.sh. 3,765,894
6 4 not 5 4247
7 limit 6 to yr=“1970 -Current” 3336
Embase (OvidSP)
Data Parameters: Embase 1980 to 2013 Week 09, Embase 1974 to 1979, Embase Classic 1947 to 1973
Strategy:
# Searches Results
1 (Thrombelastogra$ or Thromboelastogra$ or (thromb$ adj2
elastogra$) or TEG or haemoscope or haemonetics).mp
7712
2 thromboelastography/ 5167
3 (thromboelasto$ or thrombelasto$ or (thromb$ adj2 elastom$)
or (rotational adj2 thrombelast) or ROTEM or “tem interna-
tional”).mp
6740
4 1 or 2 or 3 8264
5 exp animal/ not human/ 4,754,994
6 4 not 5 7323
7 limit 6 to yr=“1970 -Current” 5913
Transfusion Evidence Library
Host: http://www.transfusionguidelines.org.uk/Index.aspx?Publication=SRI&Section=24&pageid=7559
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Data Parameters: 1980-Present
Strategy:
(Thrombelastogra* or Thromboelastogra* or (thromb* and elastogra*) or TEG or haemoscope or haemonetics) [in Search All Text]
OR (thromboelasto* or thrombelasto* or (thromb* and elastom*) or (rotational and thrombelast) or ROTEM or tem international)
[in Search All Text]
Hits: 24
British Nursing Index (Proquest) (1994 - current)
Strategy:
S1 all((Thrombelastogra* OR Thromboelastogra* OR (thromb* NEAR/2 elastogra*) OR TEG OR haemoscope OR haemonetics))
S2 (thromboelasto* OR thrombelasto* OR (thromb* NEAR/2 elastom*) OR (rotational NEAR/2 thrombelast) OR ROTEMOR tem
international)




# 1 2785 Topic=((Thrombelastogra* or Thromboelastogra* or (thromb* NEAR/2 elastogra*) or TEG or haemoscope or haemo-
netics))
Databases=BCI Timespan=1970-2013
# 2 2153 Topic=((thromboelasto* or thrombelasto* or (thromb* NEAR/2 elastom*) or (rotational NEAR/2 thrombelast) or
ROTEM or “tem international”))
Databases=BCI Timespan=1970-2013
# 3 3060 #2 OR #1
Databases=BCI Timespan=1970-2013
Centre for Reviews and Dissemination (http://www.crd.york.ac.uk/crdweb/SearchPage.asp)
Strategy:
1. (Thrombelastogra* or Thromboelastogra* or (thromb* NEAR2 elastogra*) or TEG or haemoscope or haemonetics)
2. (thromboelasto* or thrombelasto* or (thromb* NEAR2 elastom*) or (rotational N2 thrombelast) or ROTEM or tem international)
3. 1 or 2
Hits: 13
CINAHL (EBSCO Host) (1981 to present)
Strategy:
S1 TI ( (Thrombelastogra* or Thromboelastogra* or (thromb* N2 elastogra*) or TEG or haemoscope or haemonetics) ) OR AB (
(Thrombelastogra* or Thromboelastogra* or (thromb* N2 elastogra*) or TEG or haemoscope or haemonetics) )
S2 TI ( (thromboelasto* or thrombelasto* or (thromb* N2 elastom*) or (rotational N2 thrombelast) or ROTEM or tem international) )
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HMIC (OvidSP) (1979 to January 2013)
Strategy:
# Searches Results
1 (Thrombelastogra$ or Thromboelastogra$ or (thromb$ adj2
elastogra$) or TEG or haemoscope or haemonetics).mp
1
2 (thromboelasto$ or thrombelasto$ or (thromb$ adj2 elastom$)
or (rotational adj2 thrombelast) or ROTEM or “tem interna-
tional”).mp
0
3 1 or 2 1
4 limit 3 to yr=“1970 -Current” 1
PsycINFO (OvidSP) (1806 to February Week 4 2013)
Strategy:
# Searches Results
1 (Thrombelastogra$ or Thromboelastogra$ or (thromb$ adj2
elastogra$) or TEG or haemoscope or haemonetics).mp
21
2 (thromboelasto$ or thrombelasto$ or (thromb$ adj2 elastom$)
or (rotational adj2 thrombelast) or ROTEM or “tem interna-
tional”).mp
11
3 1 or 2 25
4 limit 3 to yr=“1970 -Current” 22
Hits: 22
ISI WOS: Conference Proceedings Citation Index - Science (CPCI-S) (1990-present); Conference Proceedings Citation
Index - Social Science & Humanities (CPCI-SSH) (1990-present); Science Citation Index Expanded (SCI-EXPANDED)
(1970-present); Social Sciences Citation Index (SSCI) (1970-present).
Strategy:
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# 1 3715 Topic=((Thrombelastogra* or Thromboelastogra* or (thromb* NEAR/2 elastogra*) or TEG or haemoscope or haemo-
netics))
Databases=SCI-EXPANDED, SSCI, CPCI-S, CPCI-SSH Timespan=1970-01-01 - 2013-03-04
# 2 2570 Topic=((thromboelasto* or thrombelasto* or (thromb* NEAR/2 elastom*) or (rotational NEAR/2 thrombelast) or
ROTEM or “tem international”))
Databases=SCI-EXPANDED, SSCI, CPCI-S, CPCI-SSH Timespan=1970-01-01 - 2013-03-04
# 3 4052 #2 OR #1




(Thrombelastogra* or Thromboelastogra* or (thromb* NEAR2 elastogra*) or TEG or haemoscope or haemonetics)




(Thrombelastogra* or Thromboelastogra* or TEG or thromboelasto* or thrombelasto* or ROTEM)
Hits: 25
Trials registries
Current Controlled Trials (http://www.controlled-trials.com/)
Strategy: (TEG or ROTEM)
Clinical Trials.Gov (http://clinicaltrials.gov/ct2/home)
Strategy: (TEG or ROTEM)
WHO International Trials Registry Platform (http://www.who.int/ictrp/en/)
Strategy: (TEG or ROTEM)
Websearching
• Aggressive Research Intelligence Facility (ARIF) via http://tinyurl.com/3u9tevp
• C-EBLM
• Diagnostic Test Accuracy Working Group (Cochrane) via http://srdta.cochrane.org/
• Google
• MEDION database via http://www.mediondatabase.nl/
• Haemonetics Corporation http://www.haemonetics.com/en.aspx
• TEM Innovations GmbH http://www.rotem.de/site/index.php
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Fowards Citation Chasing
Citation N
Functional definition and characterization of acute traumatic co-
agulopathy. Critical Care Medicine, 39, 2652-2658
44
Diagnosis of early coagulation abnormalities in trauma patients
by rotation thrombelastography. Journal of Thrombosis and
Haemostasis, 5, 289-295
173
Early determination of hypocoagulopathy based on interim





Unique records to screen 62
Appendix 3. Methods from protocol [Art. No.: CD010438]
Methods
Criteria for considering studies for this review
Types of studies
Cross-sectional studies investigating the diagnostic test accuracy of TEG or ROTEM in patients with clinically suspected TIC will
be eligible. We will expand the inclusion criteria to include case control studies if the number of sources retrieved is insufficient for a
valid systematic review and possible meta-analysis. Pragmatically we have set this level at less than 100 patients in total in the included
studies.
Participants
All studies including adult trauma patients with clinically suspected TIC will be eligible. Studies in both military and civilian settings
will be included.
Index tests
Two global tests of haemostatic function will be used, TEG (thromboelastography - whose name is a trademark of the Haemoscope
Corporation, USA http://www.haemoscope.com/) and ROTEM (rotational thromboelastometry - trademark of TEM International
GmbH http://www.rotem.de/site/index.php). Normal thresholds are indicated in Table 1.
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Target conditions
The target condition will be TIC defined by standard clotting times of PTr and INR.
Reference standards
In the absence of embedded clinical consensus, the coagulopathic range we will be using is based on pro-thrombin time ratio (PTr)/
International Normalized Ratio (INR), with the lower limit of the range a PTr/INR reading of 1.2 or greater Frith 2010), and the upper
limit of 1.5 or greater (Stainsby 2006). There is no upper limit to the range - anyone with a PTr/INR count of above 1.2, or above 1.5,
is considered coagulopathic. These figures were reached through discussion by the report authors, including experts in haematology
and trauma medicine.
PTr differs from INR, although the final numbers may be the same. The PTr calculated varies depending on local thresholds and
separate batches of different manufacturer’s reagent involved in conducting the prothrombin time (PT) test. In an effort to standardise
this measurement, the INR is calculated as the ratio of a patient’s prothrombin time compared to a mean normal PT (calculated by
determining the mean of 30 or more patients who are representative of the local hospital population), computed to the power of the
International Sensitivity Index (ISI), which is itself calculated by the manufacturer to give an indication of how each batch of tissue
factor corresponds to an international reference. The equation for calculation is in Figure 1.
Search methods for identification of studies
A sensitive search strategy will be used to identify literature relating to the index test for this review. This strategy will not be limited by
language but will be limited by date to 1990-current and to human only populations. The test technology has been established since
1948, but the date limit has been set to 1990 in order to maximise study quality and capture the more recent versions of the technology
in current use.
Electronic searches
The following bibliographic resources will be searched: British Nursing Index, Biosis, Centre for Reviews and Dissemination databases,
CINAHL, The Cochrane Library, Conference Proceedings Citation Index- Science (CPCI-S), Conference Proceedings Citation Index-
Social Science &Humanities (CPCI-SSH), EMBASE, HMIC, MEDLINE in Process, MEDLINE, PsycINFO, Science Citation Index
Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), LILACS and the Transfusion Evidence Library.
The following trials registers will be hand-searched: Current Controlled Trials, Clinical Trials.Gov and the WHO International Trials
Registry Platform via http://www.who.int/ictrp/en/
The following websites will be searched:
• Aggressive Research Intelligence Facility (ARIF) via http://tinyurl.com/3u9tevp
• C-EBLM
• Diagnostic Test Accuracy Working Group (Cochrane) via http://srdta.cochrane.org/
• Google
• MEDION database via http://www.mediondatabase.nl/
• http://srdta.cochrane.org/
• Haemonetics Corporation http://www.haemoscope.com/
• TEM Innovations GmbH http://www.rotem.de/site/index.php
Searching other resources
Citation chasing will be conducted on all studies included on full text. Attempts will be made to conduct authors for any additional or
supporting information. For further details on the search, including the strategy, please see Appendix 2.
Data collection and analysis
Selection of studies
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All sources will be managed using Review Manager 5 software. The inclusion criteria will be based on the “Criteria for considering
the studies for this review” detailed above. Decisions on inclusion/exclusion of studies will be made independently by two reviewers
(HH and CH) using piloted criteria. Disagreements will be resolved with reference to a third experienced reviewer (SS and PP). The
systematic review of diagnostic test accuracy of coagulation tests will target prospective cohort studies measuring accuracy relative to a
reference standard and rigorous evaluation of time taken to obtain coagulation results.
Data extraction and management
We will extract the following data (where available) into a bespoke data extraction table.
• Author, year of study, year of publication, journal reference.
• Study design and timing of data collection (prospective/retrospective).
• Study population and participant characteristics (age, sex, setting - e.g. hospital, region, country, other details given).
• Trauma type and severity (Injury Severity Score - ISS).
• Patient history.
• Pre-admission treatment, especially blood transfusion and/or additives.
• Blood temperature and duration of bleed at point of testing.
• Reference test used (PTr/INR) and any other measures taken (e.g. PT, APTT, Fibrinogen level, platelet count, fibrinogen
degradation products).
• Index test used (TEG/ROTEM) and version of device.
• Any details about device reliability.
• When tests were carried out in treatment phase (i.e. pre/post transfusion, timings).
• Data from the 2 x 2 table will be extracted where presented, i.e. true positives, false positives, true negatives and false negatives.
• QUADAS-2 items (see Table 2).
Where available, variability between operators and assay conditions will be recorded. Particular care is likely to be required on many of
these items (index test and reference standard) because of lack of standardisation. The abstraction form will be piloted by two authors
(HH and CH) using two primary diagnostic studies. A third author (NC) will resolve disagreements. The form will be accompanied by
a briefing document explaining how it should be used. Data will be abstracted by one reviewer (HH) and checked by a second (CH),
with a third author (NC) providing moderation as required.
Assessment of methodological quality
Quality assessment will be carried out using a checklist approach to assess the quality of primary studies based on the QUADAS-2
instrument (see Table 2) in line with advice given in Chapter 9, ‘Assessing Methodological Quality’ in the Cochrane Handbook for
Diagnostic Test Accuracy Reviews (Reitsma 2009). We will independently score each item as ‘Yes’, ‘No’ or ‘Unclear’, and will omit
three reporting items from the QUADAS-2 list, addressing the description of the index test, reference standard and selection criteria,
as recommended by the Cochrane Handbook for Diagnostic Test Accuracy (Deeks 2010). A categorisation of ’unclear’ will generally
be considered a marker of poor quality, so care will be taken to account for the possibility that failing to report an item was reasonable
given the circumstances in which the study was conducted. Results will be presented narratively in the text, and in an appropriate
graphic representation of quality assessment (such as a table).
Statistical analysis and data synthesis
Wewill consider the accuracy of TEG andROTEMcompared to the reference standard as detailed above. Results will be the components
of the 2 x 2 table, sensitivity and specificity and their 95% confidence intervals (CI). These will be tabulated and presented graphically
(forest plots and receiver operating characteristic (ROC) space). The initial approach to analysis is likely to be qualitative, with
conclusions based on patterns of results. Quantitative meta-analysis may be appropriate where the quantity and nature of the included
studies permit. If meta-analysis is possible, the approach will be to calculate a summary receiver operating characteristic (SROC) curve
using a hierarchical SROC (HSROC) model. Use of a bivariate model will also be considered depending on the data (Reitsma 2009),
but a priori uncertainty about thresholds and the likelihood of implicit thresholds suggests theHSROCmodel may be slightly preferable
in the first instance. A summary of results table will be generated. If feasible and appropriate, translation of any summary results into
natural frequencies and other metrics such as predictive values will be considered to facilitate improved understanding to readers.
The number of uninterpretable results will be tabulated and commented on. Analysis and presentation of results will be carried out in
line with advice in Chapter 10 of the Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy (Macaskill 2010).
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Wewill carefully scrutinise all the included studies for any further investigation of discrepant results between the index test and reference
standards (False Positives - FP - and False Negatives - FN), ideally based on independent clinical review of all available findings with
the purpose of considering whether it was global haemostatic function or traditional measures of clotting which was giving the better
indication of true disease state. Any results will tabulated and summarised narratively.
Investigations of heterogeneity
With respect to test accuracy results, we will assume that important heterogeneity beyond that accounted for by chance will be present
and will need to be investigated. Our initial approach will be to perform sequential sub-group analyses using the analytical framework
detailed below. We will consider whether using co-variates in the HSROC model will add to any insights gained from these sub-group
analyses.
The provisional framework for investigating heterogeneity will include the following.
• Type of global measure of haemostatic function (TEG/ROTEM).
• Time blood sample taken relative to trauma (< 1 h/> 1 h).
• Nature of reference standard (INR/PTr of 1.2 ≥; INR/PTr of 1.5 ≥).
• Prevalence of acute traumatic coagulopathy (ATC; excluding case-control studies if these are included).
• Participant type especially severity of trauma and mechanism of injury (blunt/penetrating).
• Setting (military or civilian).
• Whether trauma associated with massive transfusion (yes or mixed/no).
• Case-control study design (if these are included).
• Other aspects of study quality, particularly blinding of index test and reference standard.
There are no specific plans for the investigation of heterogeneity of the data concerning uninterpretable results or further investigation
of discrepant results.
Sensitivity analyses
In the unlikely event that heterogeneity is not present and the effect of important covariates has not already been analysed, we will
investigate the robustness of any summary estimates of test accuracy to the aspects of study quality indicated in the framework for
investigating heterogeneity above.
Assessment of reporting bias
We will not be assessing reporting bias because its impact in test accuracy is unclear and the tools for investigating it are in the early
stages of development.
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